Boston BioMedical Being Sold To Japanese Competitor

By Anthony Silva, WBZ NewsRadio 1030

BOSTON (CBS) – A five year old local biotech will be getting a $200 million upfront payment as part of its sale to a large Japanese drug company.

Boston Biomedical of Norwood is being purchased by Dainippon Sumitomo Pharma, in a deal that could ultimately be worth more than $700 million.

Boston Biomedical founder and CEO Chiang Li says his company is involved in cutting edge cancer research.

WBZ NewsRadio 1030’s Anthony Silva reports

More from New England Business

Leave a Reply

Please log in using one of these methods to post your comment:

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

More From CBS Boston

Opioid Crisis
Download Our App

Watch & Listen LIVE